Pharmalitet: October 2015

Wednesday, October 28, 2015

Monday, October 26, 2015

Sunday, October 25, 2015

The Supreme Personality of Godhead, by expanding His own energy, keeps this cosmic manifestation visible and again sometimes renders it invisible. He is both the supreme cause and the supreme result, the observer and the witness, in all circumstances. Thus He is transcendental to everything. May that Supreme Personality of Godhead give me protection.

Music of the week

Saturday, October 24, 2015

Quote of the day

Targeted failure of the week. Kadcyla. When rocket science medicine fails...

Oct 22 (Reuters) - ImmunoGen Inc said the gastric cancer drug it is developing with Roche Holding AG did not meet the main goal in a large study. http://finance.yahoo.com/news/immunogen-roche-gastric-cancer-drug-121659032.html

Trastuzumab emtansine ( ado-trastuzumab emtansine, trade name Kadcyla) is an antibody-drug conjugate consisting of the monoclonal antibody trastuzumab (Herceptin) linked to the cytotoxic agent DM1.